Jubilant Pharmova has announced a board meeting to consider the financial results for the quarter and half-year. The company secured full deletion of a Rs. 35.90 Cr tax demand for AY 2018-19, removing a substantial contingent liability and enhancing financial clarity. The appeal on merits continues, with no reported impact on key management litigation.